Skip to content

The differential effects of antihypertensive drugs on central blood pressure: Comparison between beta-blocker and angiotensin II receptor blocker

The differential effects of antihypertensive drugs on central blood pressure: Comparison between beta-blocker and ARB

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0003528
Enrollment
110
Registered
2019-02-19
Start date
2019-01-07
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : He visits the hospital at the address of hypertension and obtains consent form from patients who are scheduled to take anti-hypertension medication and begins his research. The medical institut

Sponsors

Korea University Anam Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients between the ages of 40 and 80 (2) Patients who are first diagnosed with high blood pressure corresponding to systolic blood pressure = 140 mmHg or loosened blood pressure = 90 mmHg (3) Patients who have already undergone a wash out of a drug that had been used for two weeks if they were diagnosed with hypertension = 140 mmHg or loosened blood pressure = 90 mmHg (4) Person who agrees to the purpose of this study and to provide clinical information

Exclusion criteria

Exclusion criteria: (1) A person who has overreaction or withdrawal symptoms in the use of anti-hypertension drugs such as beta-blockers (2) Severe hypertension patient corresponding to systolic blood pressure = 200 mmHg or relaxation pressure = 110 mmHg at any visit (3) Medications that may affect blood pressure and central arterial pressure (disease, alpha-blocking, etc.) are already being administered and cannot be stopped due to treatment of other diseases.

Design outcomes

Primary

MeasureTime frame
To find out if there is a difference in the central arterial pressure between the beta-blocker with angioplasty and the ARB.

Countries

Korea, Republic of

Contacts

Public ContactEun Hye Joung

Korea University Anam Hospital

lily931026@naver.com+82-2-920-6731

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026